IN Brief:
- Tate & Lyle has expanded its collaboration with BioHarvest Sciences to develop multiple plant-based sweetener molecules.
- The programme uses BioHarvest’s Botanical Synthesis platform to produce non-GMO plant-based ingredients without growing the source plants.
- The work supports sugar and calorie reduction across food and beverage categories where taste, labelling, and cost remain difficult to balance.
Tate & Lyle has expanded its collaboration with BioHarvest Sciences to accelerate development of next-generation plant-based sweeteners for food and beverage manufacturers.
The broader programme will focus on multiple plant-based sweetener molecules, building on the companies’ earlier work around botanical sweetening ingredients. BioHarvest’s Botanical Synthesis platform produces plant-based, non-GMO ingredients without requiring cultivation of the original plants, creating a route to molecules that can be difficult or inconsistent to source through conventional agriculture.
Tate & Lyle is using the collaboration as part of its wider sweetener innovation strategy. The company’s existing position spans sugar and calorie reduction technologies including sucralose, allulose, and stevia-derived sweetener systems, while the BioHarvest partnership adds another route into plant-derived molecules that can be adapted for different food and drink categories.
Sugar reduction remains one of the hardest reformulation tasks in industrial food production. Sweetness can be replaced, but sugar also contributes bulk, mouthfeel, browning, freezing-point control, fermentation behaviour, water activity, viscosity, and flavour release. Bakery, dairy, confectionery, sauces, and beverages all respond differently when sugar is reduced or replaced.
That makes a multi-molecule approach valuable. Beverage systems may require rapid solubility and a clean sweetness profile, while bakery products often need bulking and browning support. Dairy desserts need sweetness without bitterness or texture collapse, and sauces may need stability across pH, heat, and storage. Manufacturers need ingredient systems that can be tuned around the product matrix rather than dropped into every formulation in the same way.
Ingredient supply security is also part of the calculation. Botanical and plant-derived molecules can be constrained by crop yield, climate, land availability, extraction efficiency, and regional sourcing risk. Controlled production routes can reduce some of that variability, although scale, regulation, and cost-in-use will decide how far these technologies move beyond development pipelines.
The strategic value attached to this area is already visible in Ingredion’s proposal for Tate & Lyle, which placed speciality ingredient systems at the centre of a wider consolidation debate. Sweeteners, fibres, texturants, starches, and nutrition systems are now central to manufacturers’ efforts to manage health targets, sensory performance, and margin pressure.
Controlled production is also spreading through flavours and other functional ingredients. Fermentation-derived, bioconverted, and cell-based production routes are being used to create consistency where agricultural extraction or traditional chemistry can introduce supply, cost, or perception challenges.
For Tate & Lyle, the expanded BioHarvest collaboration strengthens its pipeline in a market where sugar reduction is no longer a single-ingredient problem. For manufacturers, it points to a future in which sweetening is engineered category by category, with molecule selection, process behaviour, sensory balance, and labelling considered as one system.
